期刊
CURRENT NEUROPHARMACOLOGY
卷 14, 期 3, 页码 282-299出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X14666151223100011
关键词
Antioxidative defence; inorganic selenium donor; neurological diseases; organic selenium donor; selenoprotein; therapy
资金
- Medical University of Warsaw [FW27/PM34D/14]
- Mossakowski Medical Research Centre, Polish Academy of Sciences
Selenium (Se-34), an antioxidant trace element, is an important regulator of brain function. These beneficial properties that Se possesses are attributed to its ability to be incorporated into selenoproteins as an amino acid. Several selenoproteins are expressed in the brain, in which some of them, e.g. glutathione peroxidases (GPxs), thioredoxin reductases (TrxRs) or selenoprotein P (SelP), are strongly involved in antioxidant defence and in maintaining intercellular reducing conditions. Since increased oxidative stress has been implicated in neurological disorders, including Parkinson's disease, Alzheimer's disease, stroke, epilepsy and others, a growing body of evidence suggests that Se depletion followed by decreased activity of Se-dependent enzymes may be important factors connected with those pathologies. Undoubtedly, the remarkable progress that has been made in understanding the biological function of Se in the brain has opened up new potential possibilities for the treatment of neurological diseases by using Se as a potential drug. However, further research in the search for optimal Se donors is necessary in order to achieve an effective and safe therapeutic income.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据